Impella Ventricular Assist Device - Sport

NEW ORLEANS – The Impella 5.0 and 5.5 left ventricular assist device failed to measure up on outcomes when used for high-risk patients undergoing ventricular tachycardia (VT) ablation therapies, ... Abiomed Inc., has worked the ventricular assist device (VAD) space for a number of years with its Impella series of VADs, and a study coming out of Japan seems to affirm investors’ confidence in these ... TCTMD: The Impact of Preoperative Impella Support on Left Ventricular Assist Device Survival and Quality of Life The Impact of Preoperative Impella Support on Left Ventricular Assist Device Survival and Quality of Life Healio: Percutaneous ventricular assist devices yield similar periprocedural outcomes in high-risk PCI Science Daily: Successful cardiogenic shock treatment using a percutaneous left ventricular assist device Two separate randomized trials of Johnson & Johnson’s miniaturized Impella heart pumps failed to illustrate the devices’ benefits, spanning specific cases in patients with blockages in their coronary ...

BioWorld: Abiomed’s Impella devices show well in Japanese study of cardiogenic shock